Stock Price
3.64
Daily Change
-0.04 -1.09%
Monthly
0.28%
Yearly
8.98%
Q1 Forecast
3.54

Acasti Pharma reported $-4.76M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Acasti Pharma USD -4.76M 4.76M Dec/2024
Addus HomeCare USD 362.3M 12.9M Sep/2025
Amarin USD 49.67M 23.07M Sep/2025
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Option Care Health USD 1.44B 20M Sep/2025
Organigram Holdings CAD 80.06M 9.27M Sep/2025
Tilray USD 217.51M 74.75M Dec/2025